Skip to content

A clinical trial for evaluating diagnostic utility of magnified endoscopic examination with narrow band imaging (NBI) for reddish depressive lesion in stomach

A clinical trial for evaluating diagnostic utility of magnified endoscopic examination with narrow band imaging (NBI) for reddish depressive lesion in stomach - Endoscopic diagnosis for gastric reddish depressive lesion by NBI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003408
Enrollment
752
Registered
2010-04-01
Start date
2010-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reddish depressive lesion in stomach

Interventions

Magnified gastrointestinal endoscopy with NBI system Normal white light gastrointestinal endoscopy

Sponsors

First Department of Internal Medicine, Sapporo Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who will have newly detected gastric depressed lesion, which needs to be biopsied for diagnosis, in upper gastrointestinal screening by regular endoscopy.

Exclusion criteria

Exclusion criteria: 1. Lesions already diagnosed before the study 2. Obvious carcinoma 3. Non-epithelial tumor 4. Lesions which cannot be biopsied (e.g. because recipients receive anti-platelet therapy) 5. Lesions which cannot be pathologically diagnosed (e.g. because specimen is too small to be diagnosed" 6. Lesions detected by trans-nasal upper gastrointestinal endoscopy

Design outcomes

Primary

MeasureTime frame
To evaluate the following outcomes of magnifying endoscopy with NBI compared with those of normal white light endoscopy, when we diagnose reddish depressive lesion in stomach using these devices. 1. Primary outcomes: 1) exact diagnostic rate (verified by pathological examination), 2) sensitivity, specificity, positive predictive value, and negative predictive value (for cancer diagnosis)

Secondary

MeasureTime frame
2. Secondary outcomes: 1) to determine useful findings of magnifying endoscopy with NBI to discriminate gastric cancer from benign lesion, 2) to evaluate whether magnifying endoscopy with NBI needs extra time during examination, compared with normal white light endoscopy

Countries

Japan

Contacts

Public ContactTokuma Tanuma

Sapporo Medical University School of Medicine First Dept. of Int. Med.

ttokuma@sapmed.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026